-
Rotenone B5462: Reliable Mitochondrial Stress Models
2026-09-12
This scenario-based guide explains how Rotenone (SKU B5462) can improve experimental planning for mitochondrial dysfunction, viability, apoptosis, and neurodegenerative disease studies. It covers mechanism, cell-model compatibility, stock preparation, data interpretation, and practical vendor-selection criteria with links to product and literature evidence.
-
Ibrutinib (PCI-32765) BTK Assay Guide
2026-09-11
A scenario-driven guide to using Ibrutinib (PCI-32765), SKU A3001, in B-cell viability, proliferation, and cytotoxicity workflows. It explains mechanism-aware assay design, solvent handling, interpretation limits, and practical criteria for selecting a well-documented BTK inhibitor.
-
Axitinib (AG 013736) Assay Workflows
2026-09-11
Build more informative Axitinib assays by pairing VEGF pathway engagement with separate measures of growth inhibition and cell death. This workflow connects endothelial-cell screening, cancer biology research, and tumor growth inhibition in xenograft models while addressing solubility, timing, and data-interpretation pitfalls.
-
QNZ (EVP4593) in NF-κB Osteomyelitis Research
2026-09-10
QNZ (EVP4593) provides a reversible, nanomolar perturbation tool for separating NF-κB-driven inflammation from fibrosis, perfusion loss, and bacterial persistence in osteomyelitis models. This workflow pairs pathway assays with spatial tissue readouts and extends cautiously to Huntington’s disease research without overstating cross-model evidence.
-
Dronedarone (Multaq): Reading Ion-Channel Data
2026-09-10
Dronedarone and Multaq are examined through a mechanistic lens that separates broad antiarrhythmic pharmacology from direct KCa2-channel activity. This evidence-led guide translates automated patch-clamp findings into better assay design, compound handling, and atrial fibrillation treatment research decisions.
-
D-N-Acetylgalactosamine Workflow Guide
2026-09-09
D-N-Acetylgalactosamine is a defined, high-purity reagent for workflows examining brain glycoproteins, heteropolysaccharides, and related glycosylation measurements. It is suitable for water- or DMSO-based preparation, but not for ethanol-dependent methods or long-term storage of prepared solutions.
-
NIAGEN and the Next Era of Translational Cell Models
2026-09-09
Nicotinamide Riboside Chloride (NIAGEN) offers translational researchers a practical route to interrogate NAD+ biology in metabolic dysfunction research, neurodegenerative disease models, and stem cell-derived retinal ganglion cell workflows. This article connects the compound’s mechanistic rationale with reproducible differentiation strategies while distinguishing established evidence from testable opportunities.
-
PYR-41: Mapping E1 Control of IRF7 Decay
2026-09-08
PYR-41, an inhibitor of Ubiquitin-Activating Enzyme E1, offers a mechanistic way to interrogate ubiquitin-dependent IRF7 turnover and inflammatory signaling. This assay-focused guide connects the compound to recent IBDV–VP3 research while defining controls, limitations, and practical workflow decisions.
-
Cell Integrity Limits Ploidy in Budding Yeast
2026-09-08
Barker, Murray, and Bell show that budding yeast can undergo repeated genome duplication to reach approximately 32–64C, but further ploidy increases are constrained by cell surface integrity rather than DNA content alone. Their two-route endoreplication strategy links genome expansion, cell growth, surface stress, and repression of ergosterol-biosynthesis genes, providing a framework for studying how fungal cells tolerate membrane-associated stress.
-
Sulfo-NHS-Biotin for BAT Receptor Assays
2026-09-07
Discover how Sulfo-NHS-Biotin can resolve cell-surface receptor questions arising from PZP-driven brown adipose thermogenesis. This guide connects amine-reactive labeling chemistry with assay controls for distinguishing surface GRP78 from total cellular protein.
-
Targeted Fabp4 CRISPRi for Obesity and Liver Disease
2026-09-07
The reference study combines adipose-targeting peptide delivery with dCas9-based CRISPR interference to silence Fabp4 selectively in white adipocytes. In obese mice, this intervention reduced adiposity and inflammation while improving hepatic steatosis and insulin resistance, illustrating how tissue-specific nonviral delivery can broaden metabolic gene-therapy strategies.
-
PBS Liposomes for Macrophage Depletion Controls
2026-09-05
PBS Liposomes provide a phagocytosis-matched, non-depleting comparator for separating clodronate cargo effects from liposome delivery effects. This guide translates that control logic into reproducible in vivo workflows, uptake assays, troubleshooting steps, and mechanism-aware study design.
-
2-NBDG: From Uptake Signal to Mechanism
2026-09-04
2-NBDG can do more than quantify cellular glucose entry. This mechanistic guide shows how to interpret transporter uptake, hexokinase-dependent retention, and assay artifacts when studying glucose metabolism, toxicology, cancer, and diabetes research.
-
Chlorambucil: Reading Cell-Killing Data Correctly
2026-09-04
Chlorambucil is a nitrogen mustard alkylating agent whose apparent potency can change with the assay endpoint. This guide applies a dissertation-derived framework to distinguish growth inhibition from true cell death and improve interpretation across cancer models.
-
A23187, Free Acid: From Calcium Flux to Translation
2026-09-03
A mechanistic and translational framework for using A23187, free acid as a calcium ionophore in cell-based research. The article connects intracellular Ca2+ elevation with phosphoinositide signaling, ROS generation, mitochondrial permeability transition, and context-dependent cell death while showing why calcium flux should not be treated as a surrogate for apoptosis. It also provides workflow guidance, product-handling considerations, and a strategy for positioning A23187 as a benchmark perturbation in in vitro drug-response studies.